CN100344316C - Chinese medicine for treating myasthenia gravis - Google Patents
Chinese medicine for treating myasthenia gravis Download PDFInfo
- Publication number
- CN100344316C CN100344316C CNB2005100456443A CN200510045644A CN100344316C CN 100344316 C CN100344316 C CN 100344316C CN B2005100456443 A CNB2005100456443 A CN B2005100456443A CN 200510045644 A CN200510045644 A CN 200510045644A CN 100344316 C CN100344316 C CN 100344316C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- traditional chinese
- myasthenia gravis
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention belongs to a traditional Chinese medicine, specifically a traditional Chinese medicine for treating myasthenia gravis. The traditional Chinese medicine for treating myasthenia gravis is prepared from the following traditional Chinese medicines of tangshen, tuckahoe, rhizoma, common yan rhizome, kudzuvine root, prepared rehmannia root, eucommia bark, pilose antler, wolfberry fruit, nutgrass galingale rhizome, milkvetch root, cornel, bupleurum root, angelica, Chinese taxillus twig, largetrifoliolious bugbane rhizome, twotoothed achyranthes root, fleeceflower root and dendrobium. The traditional Chinese medicines are processed by conventional traditional Chinese medicine technology for preparing pills, powder and medicinal granules. The traditional Chinese medicine for treating myasthenia gravis in the present invention has the efficiency of replenishing Qi to invigorate the spleen, strengthening the body to increase the essence, nourishing the liver, nourishing the kidney and completely treating diseases with outstanding and obvious curative effect.
Description
Technical field
The invention belongs to Chinese medicine, a kind of Chinese medicine for the treatment of myasthenia gravis of saying so more accurately.
Background technology
The myasthenia gravis disease is a kind of disease of still not having the clear and definite cause of disease up to now, main disease show as the ptosis, diplopia, language unclear, chew dysphagia, difficulty, severe patient dyspnea come back.Be commonly considered as being directed at, or the autoimmunity of thinking dysfunction institute arranged extremely owing to the propagation function obstacle of neuromuscular junction.At present doctor trained in Western medicine mainly adopts bromine than the bright of this or hormone medicine symptomatic treatment to the myasthenia gravis disease, can the respite symptom, but can't reach the purpose of radical cure.
Summary of the invention
Given this, the object of the present invention is to provide a kind of Chinese medicine that can treat myasthenia gravis.
Purpose of the present invention is achieved through the following technical solutions: a kind of Chinese medicine for the treatment of myasthenia gravis is made up of the Chinese medicine of following prescription:
Radix Codonopsis 10-20g Poria 10-20g Rhizoma Atractylodis Macrocephalae 10-20g
Rhizoma Dioscoreae 10-20g Radix Puerariae 5-10g Radix Rehmanniae Preparata 10g-20g
Cortex Eucommiae 10-20g Cornu Cervi Pantotrichum 1-3g Fructus Lycii 10-20g
Rhizoma Cyperi 5-15g Radix Astragali 10-15g Fructus Corni 5-15g
Radix Bupleuri 3-6g Radix Angelicae Sinensis 10-15g Herba Taxilli 10-25g
Rhizoma Cimicifugae 2-9g Radix Achyranthis Bidentatae 10-20g Radix Polygoni Multiflori 10-20g
Herba Dendrobii 6-20g Radix Saposhnikoviae 5-10g
By the Chinese medicine of above-mentioned prescription,, produce ball, diffusing, decoction by conventional Chinese medicine processing technique.
29 years old case record of case 1. Luo Yuanyuan woman number: 1586
Medical history 1 year, two upper eyelids are sagging, and diplopia is without language barrier, chews and swallows normally, and it is normal to walk.Diagnosis: ocular type myasthenia gravis.
Clinically take decoction of the present invention, day clothes 2 times were taken medicine 10, and sx was taken medicine 30, and recovery from illness continues medication and consolidated in 6 months, and clinical cure was followed up a case by regular visits to 10 years, recurrence.
35 years old case record of case 2. Yang Jun woman number: 1676
Medical history 3 years, two upper eyelids are sagging, increase the weight of because of the flu state of an illness when diplopia, aphasis, dysmasesis, dysphagia, prescription on individual diagnosis, and dyspnea is unable to leave the bed.Clinical diagnosis: myasthenia gravis crisis.Take decoction of the present invention, sx after 7 days calmed down after 2 months, consolidated medication 6 months, and recurrence at the year ends 8 is followed up a case by regular visits in recovery from illness.
The Chinese medicine of treatment myasthenia gravis of the present invention, replenishing QI to invigorate the spleen, building up the spleen to supplement the lung, the liver and kidney nourishing have the function for the treatment of both the principal and secondary aspects of a disease, determined curative effect, effect is remarkable.
The specific embodiment
A kind of Chinese medicine for the treatment of myasthenia gravis is made up of the Chinese medicine of following prescription:
Get:
Radix Codonopsis 15g Poria 15g Rhizoma Atractylodis Macrocephalae 15g
Rhizoma Dioscoreae 15g Radix Puerariae 5g Radix Rehmanniae Preparata 15g
Cortex Eucommiae 15g Cornu Cervi Pantotrichum 2g Fructus Lycii 15g
Rhizoma Cyperi 10g Radix Astragali 15g Fructus Corni 10g
Radix Bupleuri 5g Radix Angelicae Sinensis 15g Herba Taxilli 15g
Rhizoma Cimicifugae 5g Radix Achyranthis Bidentatae 15g Radix Polygoni Multiflori 15g
Herba Dendrobii 10g Radix Saposhnikoviae 5g
By the Chinese medicine of above-mentioned prescription,, produce decoction by conventional Chinese medicine processing technique.
Adopt the 34 routine clinical sights of above-mentioned decoction treatment myasthenia gravis disease to look into report
Key word: myasthenia gravis Chinese medicine decoction
Summary: purpose: understand treatment myasthenia gravis Chinese medicine clinical therapeutic efficacy
Method: adopt the stochastic sampling double-blind method, observe therapeutic effect and the safety thereof of decoction to 34 routine myasthenia gravis patients.
Do not find any side effect in clinical.
Conclusion: determined curative effect, safe and practical.
1. materials and methods
Resemble 1.1 see to check
Medication same period myasthenia gravis patient 17 examples, age 18-45 year.
1.2 therapeutic regimen
Full group patient is divided into treatment at random by double-blind method and organizes 34 examples.The treatment group gives decoction oral medicinal herb treatment, 1 twice-daily, early, dinner takes after half an hour.
1.3 sight checking method
Before treating, the each patient all writes down medical history, sign, and relevant physics, physiology inspection.
1.4 therapeutic effect is seen and is looked into
The patient 30 days was a course of treatment with medication, and the treatment phase is 1-3 the course of treatment.
Criterion of therapeutical effect:
A is invalid: the treatment back does not have change with the preceding state of an illness symptom of treatment.
B is effective: treatment back state of an illness sign has improvement.
The C produce effects: treatment back state of an illness sign has clear improvement.
The D recovery from illness: treatment back disease all disappears, and reaches the clinical cure standard.
Treatment is analyzed
All clinical datas are judged comparison with the treatment group in invalid, effective, produce effects, four standards of recovery from illness behind finishing analysis, by statistical procedures, see the significance of looking into its difference,
2. result
The 2-1 curative effect
This group 34 examples are used decoction treatment by Chinese herbs myasthenia gravis patient efficacy result
| Diagnosis | The example number | Curative effect | |||
| Invalid | Effectively | Produce effects | Recovery from illness | ||
| Myasthenia gravis | 34 | 5 | 11 | 18 | |
34 routine patient treatment curative effect statistical tables
| Group | The example number | Curative effect | |||
| Invalid % | Effective % | Produce effects % | Recovery from illness % | ||
| Decoction treatment group | 14.7 | 32.3 | 53 | ||
Statistical procedures
P＜0.01
2.2 toxic and side effects
Toxic and side effects such as discomfort appear in 34 none example of example treatment patient.Test check blood, urine, the just all no abnormal change of routine, liver, renal function.Point out decoction safety of the present invention thus, without any side effects.
Claims (1)
1. a Chinese medicine for the treatment of myasthenia gravis is characterized in that: by following group
The Chinese medicine of side is made:
Radix Codonopsis 10-20g Poria 10-20g Rhizoma Atractylodis Macrocephalae 10-20g
Rhizoma Dioscoreae 10-20g Radix Puerariae 5-10g Radix Rehmanniae Preparata 10g-20g
Cortex Eucommiae 10-20g Cornu Cervi Pantotrichum 1-3g Fructus Lycii 10-20g
Rhizoma Cyperi 5-15g Radix Astragali 10-15g Fructus Corni 5-15g
Radix Bupleuri 3-6g Radix Angelicae Sinensis 10-15g Herba Taxilli 10-25g
Rhizoma Cimicifugae 2-9g Radix Achyranthis Bidentatae 10-20g Radix Polygoni Multiflori 10-20g
Herba Dendrobii 6-20g Radix Saposhnikoviae 5-10g
By the Chinese medicine of above-mentioned prescription,, produce ball, diffusing, decoction by conventional Chinese medicine processing technique.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456443A CN100344316C (en) | 2005-01-12 | 2005-01-12 | Chinese medicine for treating myasthenia gravis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100456443A CN100344316C (en) | 2005-01-12 | 2005-01-12 | Chinese medicine for treating myasthenia gravis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1679905A CN1679905A (en) | 2005-10-12 |
| CN100344316C true CN100344316C (en) | 2007-10-24 |
Family
ID=35066911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100456443A Expired - Fee Related CN100344316C (en) | 2005-01-12 | 2005-01-12 | Chinese medicine for treating myasthenia gravis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100344316C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101590189B (en) * | 2008-05-29 | 2012-05-30 | 河北以岭医药研究院有限公司 | Traditional Chinese medicine composition containing radix aconiti carmichaeli for treating myasthenia gravis and preparation thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007112B (en) * | 2006-09-29 | 2011-05-04 | 辽宁中医药大学 | A traditional Chinese medicine for treating myasthenia gravis and its producing method |
| CN101293043B (en) * | 2007-04-24 | 2011-07-13 | 上海中医药大学附属曙光医院 | Pharmaceutical formulation for treating muscular atrophy lateral sclerosis and preparing method |
| CN101496865B (en) * | 2009-03-19 | 2011-06-15 | 杨颖� | Chinese medicament preparation for treating depression and anxiety as well as preparation method thereof |
| CN103041228A (en) * | 2013-01-10 | 2013-04-17 | 尹爱良 | Traditional Chinese medicine composite for treating myasthenia gravis |
| CN104069339B (en) * | 2014-06-18 | 2017-02-15 | 乞国艳 | Traditional Chinese medicine composition for treating myasthenia gravis and preparation method thereof |
| CN104173669A (en) * | 2014-09-02 | 2014-12-03 | 王霞 | Drug for treating myasthenia gravis and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1181967A (en) * | 1997-10-22 | 1998-05-20 | 薛廷民 | Shengguipeiyuan medicine granule for curing serious amyasthenia and its preparation |
| CN1183980A (en) * | 1997-08-02 | 1998-06-10 | 迟经惠 | Decoction for serious amyasthenia |
| CN1049130C (en) * | 1994-07-19 | 2000-02-09 | 尚尔寿 | Medicine for treating myasthenia gravis "Qiang-Ji-Ning" |
| CN1342467A (en) * | 2000-09-08 | 2002-04-03 | 姜东海 | Medicine for treating myashthenia gravis |
-
2005
- 2005-01-12 CN CNB2005100456443A patent/CN100344316C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049130C (en) * | 1994-07-19 | 2000-02-09 | 尚尔寿 | Medicine for treating myasthenia gravis "Qiang-Ji-Ning" |
| CN1183980A (en) * | 1997-08-02 | 1998-06-10 | 迟经惠 | Decoction for serious amyasthenia |
| CN1181967A (en) * | 1997-10-22 | 1998-05-20 | 薛廷民 | Shengguipeiyuan medicine granule for curing serious amyasthenia and its preparation |
| CN1342467A (en) * | 2000-09-08 | 2002-04-03 | 姜东海 | Medicine for treating myashthenia gravis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101590189B (en) * | 2008-05-29 | 2012-05-30 | 河北以岭医药研究院有限公司 | Traditional Chinese medicine composition containing radix aconiti carmichaeli for treating myasthenia gravis and preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1679905A (en) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100344316C (en) | Chinese medicine for treating myasthenia gravis | |
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1679904A (en) | Chinese medicine for treating cardiac failure | |
| CN1203879C (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN102335366B (en) | Oral liquor for treating psoriasis and preparation method thereof | |
| CN1806834A (en) | Chinese medicine for treating AIDS | |
| CN1149097C (en) | Chinese patent medicine for curing diabetes | |
| CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
| CN102657706A (en) | Infantile anti-cold umbilical therapeutic ointment | |
| CN1539494A (en) | Chinese traditional medicine for raising immunocompetence of body for anti influenza, SARS, and preparation method | |
| CN1294980C (en) | Medicine for treating liver disease | |
| CN1095371C (en) | Capsule for treating bone diseaes | |
| CN1178110A (en) | Medicine for lung cancer | |
| CN1943691A (en) | A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method | |
| CN1063083C (en) | Anti-senility medicine and its preparation | |
| CN103948878A (en) | Traditional Chinese medicinal composition for treating bone diseases | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN1183946C (en) | Medicines for treating depression and preparation thereof | |
| CN103860964B (en) | A kind of medicament for the treatment of adults with Kashin-Beck disease | |
| CN104644950A (en) | Ointment for treating rheumatoid arthritis and preparation method of ointment | |
| CN1994428A (en) | Chinese medicine for treating ischemic necrosis of femoral head | |
| CN1352966A (en) | Medicine for treating tracheitis and asthma | |
| CN1739749A (en) | Leukemia treating Chinese medicine composition and its prepn | |
| CN1765415A (en) | Piles ointment and its preparation method | |
| CN104162104A (en) | Medicine for treating chronic atrophic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071024 Termination date: 20120112 |